Showing results (321-330 of 371) with videos related to

Sort By:
Pageof 38
European Journal of Cancer (Oxford, England : 1990)|May 30, 2009
Variants of the xeroderma pigmentosum variant gene (POLH) are associated with melanoma riskJulie Di Lucca, Mickael Guedj, Jean-Jacques Lacapère, et al.
American Journal of Medical Genetics|November 15, 2000
Cardiovascular malformations and other cardiovascular abnormalities in neurofibromatosis 1A E Lin, P H Birch, B R Korf, et al.
The Journal of Investigative Dermatology|January 26, 2018
Cyclosporine for Epidermal Necrolysis: Absence of Beneficial Effect in a Retrospective Cohort of 174 Patients-Exposed/Unexposed and Propensity Score-Matched AnalysesFlorence Poizeau, Olivier Gaudin, Laurence Le Cleach, et al.
Journal of Medical Genetics|April 16, 2009
SPRED1 germline mutations caused a neurofibromatosis type 1 overlapping phenotypeE Pasmant, A Sabbagh, N Hanna, et al.
Trauma, Violence & Abuse|April 20, 2026
Old Scars Don't Hurt? A Systematic Review on the Association Between Child Maltreatment and Adult Social FunctioningIsabelle Göhre, Lea Vogel, Tanja Brückl, et al.
The Journal of Clinical Investigation|April 3, 2020
Hair follicle stem cell replication stress drives IFI16/STING-dependent inflammation in hidradenitis suppurativaCindy Orvain, Yea-Lih Lin, Francette Jean-Louis, et al.
The British Journal of Dermatology|October 13, 2023
Identification of potential common genetic modifiers of neurofibromas: a genome-wide association study in 1333 patients with neurofibromatosis type 1Laurence Pacot, Audrey Sabbagh, Pierre Sohier, et al.
Neurology|July 11, 2018
Cutaneous neurofibromas: Current clinical and pathologic issuesNicolas Ortonne, Pierre Wolkenstein, Jaishri O Blakeley, et al.
The Journal of Investigative Dermatology|June 18, 2023
Current and Emerging Imaging Techniques for Neurofibromatosis Type 1-Associated Cutaneous NeurofibromasYingjoy Li, Jaishri O Blakeley, Ina Ly, et al.
International Journal of Cancer|August 30, 2018
Optimal oncologic management and mTOR inhibitor introduction are safe and improve survival in kidney and liver allograft recipients with de novo carcinomaBenoit Rousseau, Aude Guillemin, Christophe Duvoux, et al.
Pageof 38